157 related articles for article (PubMed ID: 20209099)
1. Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.
Zhao Y; Xu D; Jiang Y; Zhang L
PLoS One; 2010 Mar; 5(3):e9459. PubMed ID: 20209099
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties.
Zhang L; Zhang J; Lambert Q; Der CJ; Del Valle L; Miklossy J; Khalili K; Zhou Y; Pagano JS
J Virol; 2004 Dec; 78(23):12987-95. PubMed ID: 15542650
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes.
Xu D; Zhao L; Del Valle L; Miklossy J; Zhang L
J Virol; 2008 Jul; 82(13):6251-8. PubMed ID: 18417578
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
Martin HJ; Lee JM; Walls D; Hayward SD
J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation.
Zhang L; Pagano JS
Semin Cancer Biol; 2001 Dec; 11(6):445-53. PubMed ID: 11669606
[TBL] [Abstract][Full Text] [Related]
6. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.
Zhang L; Pagano JS
Mol Cell Biol; 1997 Oct; 17(10):5748-57. PubMed ID: 9315633
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 7 is involved in the growth of Epstein-Barr virus-transformed human B lymphocytes.
Xu D; Zhang Y; Zhao L; Cao M; Lingel A; Zhang L
Virus Res; 2015 Jan; 195():112-8. PubMed ID: 25300801
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.
Xu D; Meyer F; Ehlers E; Blasnitz L; Zhang L
J Biol Chem; 2011 May; 286(20):18261-7. PubMed ID: 21454650
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.
Wang L; Toomey NL; Diaz LA; Walker G; Ramos JC; Barber GN; Ning S
J Virol; 2011 Aug; 85(16):8328-37. PubMed ID: 21680528
[TBL] [Abstract][Full Text] [Related]
10. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
11. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production.
Xu D; Brumm K; Zhang L
J Biol Chem; 2006 Apr; 281(14):9163-9. PubMed ID: 16469740
[TBL] [Abstract][Full Text] [Related]
12. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
13. Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
Zhang L; Wu L; Hong K; Pagano JS
J Virol; 2001 Dec; 75(24):12393-401. PubMed ID: 11711629
[TBL] [Abstract][Full Text] [Related]
14. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.
Zhang L; Pagano JS
J Virol; 2001 Jan; 75(1):341-50. PubMed ID: 11119603
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of IRF-7.
Zhang L; Pagano JS
J Interferon Cytokine Res; 2002 Jan; 22(1):95-101. PubMed ID: 11846980
[TBL] [Abstract][Full Text] [Related]
17. Expression of latent membrane proteins in Epstein‑Barr virus-transformed lymphocytes in vitro.
Tang Y; Luo C; Cheng A; Lu S; Xu J; Fu T; Gan R
Mol Med Rep; 2014 Aug; 10(2):1117-21. PubMed ID: 24919846
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of interferon regulatory factor 7 (IRF7) with latent membrane protein 1 (LMP1) of Epstein-Barr virus.
Kim IW; Park HS
J Korean Med Sci; 2006 Jun; 21(3):379-84. PubMed ID: 16778376
[TBL] [Abstract][Full Text] [Related]
19. Multiple signal transducers and activators of transcription are induced by EBV LMP-1.
Zhang L; Hong K; Zhang J; Pagano JS
Virology; 2004 May; 323(1):141-52. PubMed ID: 15165826
[TBL] [Abstract][Full Text] [Related]
20. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
Terrin L; Dolcetti R; Corradini I; Indraccolo S; Dal Col J; Bertorelle R; Bonaldi L; Esposito G; De Rossi A
Int J Cancer; 2007 Aug; 121(3):576-87. PubMed ID: 17417773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
